Skip to main content

FDA Approves Bioventus’ Therapy for Knee Pain

Durham-based Bioventus, a global orthobiologics company, has received approval from the U.S. Food and Drug Administration to market Durolane, a single-injection joint lubricant for treating pain from knee osteoarthritis.

Grid Therapeutics Acquires Rights to Antibody for Cancer Immunotherapy

Durham-based Grid Therapeutics, an oncology-focused biotechnology company, has signed an exclusive license agreement with Duke University to develop the first human-derived antibody as a targeted immunotherapy for cancer. 

NCBiotech Funding Supports Portable Cervical Cancer Device Development

A $75,000 grant from the North Carolina Biotechnology Center is helping Duke University researchers develop a cervical cancer screening tool that women everywhere might be able to use on themselves.

Seqirus Meets New Milestone in Pandemic Preparedness

Seqirus, the Holly Springs vaccine manufacturer, recently achieved another major milestone in its efforts to support the U.S. government’s pandemic preparedness efforts, showing it can now produce 150 million doses of a mammalian cell-derived flu vaccine in the first six months of pandemic declaration.

Aerie Pharmaceuticals Expanding in Durham

California-based Aerie Pharmaceuticals, a clinical-stage company developing new treatments for glaucoma and other eye diseases, is expanding its R&D operations in Durham as some of its drug candidates move closer to commercialization.

Cempra, Melinta Therapeutics to Merge

Chapel Hill-based Cempra, a publicly held pharmaceutical company developing treatments for infectious diseases, plans to merge with privately held Melinta Therapeutics, an antibiotics developer based in New Haven, Conn.

Pfizer Boosts North Carolina Footprint with $100 Million Expansion

Pfizer, the global pharmaceutical giant, will expand its vaccine-manufacturing plant in Sanford with a $100 million investment in gene therapy that will add 40 jobs to its workforce.

Lifestar Pharma Enters NC with Purchase of Durham Facility

Citing the Research Triangle region’s prevalence of top talent and nationally ranked research universities, New Jersey-based Lifestar Pharma has purchased a Durham building for a new R&D and manufacturing operation.

Research Triangle Foundation Hires Levitan as President, CEO

Scott Levitan starts a new job today, as president and CEO of The Research Foundation of NC.

BioFluidica Raises $4.1M for Cancer Diagnosis Development

BioFluidica, a Chapel Hill company developing a product using liquid biopsies for cancer detection, has raised $4.1 million in a private equity offering. 

Pages

Subscribe to RSS - Triangle